{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:09:06Z","timestamp":1795165746039,"version":"4.10.3"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renal replacement therapy (RRT) is frequently used in critically ill patients with acute kidney injury (AKI). Here, we provide guidelines for the management of RRT in critically ill patients on the intensive care unit (ICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We convened a systemic literature research and a Delphi process with a bi-national multidisciplinary consensus panel including 22 clinicians of 12 different German-speaking societies (Germany and Austria) with expertise in RRT. This structured guideline process was the basis for the evidence-based statements and recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified seven clinical areas needing guidance: (1) start, (2) modality (diffusion and convection), (3) continuous\/ intermittent, (4) anticoagulation, (5) dose (6) pharmacotherapy, (7) stopping criteria. The consensus produced 73 statements and recommendations regarding key clinical areas, the most important 47 statements and recommendations are summarized in this overview.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This evidence-based bi-national guideline should provide physicians with guidance for delivering best practice to critically ill patients with a dialysis-dependent AKI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-025-05817-6","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:54:09Z","timestamp":1768384449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multidisciplinary guidelines on renal replacement therapy in intensive care medicine"],"prefix":"10.1186","volume":"30","author":[{"given":"Melanie","family":"Meersch-Dini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Abu-Tair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Bellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brunkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Custodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"J\u00f6rres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Kindgen-Milles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Koczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schlieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Willam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"8","key":"5817_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411\u201323.","journal-title":"Intensive Care Med"},{"key":"5817_CR2","first-page":"1","volume":"2","author":"JALN Kellum","year":"2012","unstructured":"Kellum JALN, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, et al. Clinical practice guideline for acte kidney injury 2012. Kidney Int Suppl. 2012;2:1\u2013138.","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"5817_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5195\/jmla.2018.345","volume":"106","author":"MB Eriksen","year":"2018","unstructured":"Eriksen MB, Frandsen TF. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc. 2018;106(4):420\u201331.","journal-title":"J Med Libr Assoc"},{"key":"5817_CR4","doi-asserted-by":"crossref","unstructured":"Investigators S-A, Canadian Critical Care Trials G, Australian, New Zealand Intensive Care Society Clinical Trials G, United Kingdom Critical Care Research G, Canadian Nephrology Trials N. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240\u201351.","DOI":"10.1056\/NEJMoa2000741"},{"key":"5817_CR5","doi-asserted-by":"crossref","unstructured":"Palevsky PM, Zhang JHY, O\u2019Connor TZ, Chertow GM, Crowley ST, Choudhury D et al. vol 359, pg 7,. Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury (2008). New Engl J Med. 2009;361(24):2391-.","DOI":"10.1056\/NEJMx090062"},{"issue":"1","key":"5817_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"VNARFT Network","year":"2008","unstructured":"Network VNARFT, Palevsky PM, Zhang JH, O\u2019Connor TZ, Chertow GM, Crowley ST, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7\u201320.","journal-title":"N Engl J Med"},{"issue":"20","key":"5817_CR7","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1001\/jama.2016.5828","volume":"315","author":"A Zarbock","year":"2016","unstructured":"Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315(20):2190\u20139.","journal-title":"JAMA"},{"key":"5817_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010613.pub2","author":"AI Fayad","year":"2016","unstructured":"Fayad AI, Buamscha DG, Ciapponi A. Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev. 2016. Issue 10 . https:\/\/doi.org\/10.1002\/14651858.CD010613.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"5817_CR9","volume":"11","author":"AI Fayad","year":"2022","unstructured":"Fayad AI, Buamscha DG, Ciapponi A. Timing of kidney replacement therapy initiation for acute kidney injury. Cochrane Database Syst Rev. 2022;11(11):CD010612.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10281","key":"5817_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(21)00350-0","volume":"397","author":"S Gaudry","year":"2021","unstructured":"Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021;397(10281):1293\u2013300.","journal-title":"Lancet"},{"issue":"1","key":"5817_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13613-022-01066-w","volume":"12","author":"A Sitbon","year":"2022","unstructured":"Sitbon A, Darmon M, Geri G, Jaubert P, Lamouche-Wilquin P, Monet C, et al. Accuracy of clinicians\u2019 ability to predict the need for renal replacement therapy: a prospective multicenter study. Ann Intensive Care. 2022;12(1):95.","journal-title":"Ann Intensive Care"},{"issue":"12","key":"5817_CR12","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s00134-022-06912-w","volume":"48","author":"SM Bagshaw","year":"2022","unstructured":"Bagshaw SM, Neto AS, Smith O, Weir M, Qiu H, Du B, et al. Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial. Intensive Care Med. 2022;48(12):1736\u201350.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5817_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00134-023-07211-8","volume":"49","author":"R Wald","year":"2023","unstructured":"Wald R, Gaudry S, da Costa BR, Adhikari NKJ, Bellomo R, Du B, et al. Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial. Intensive Care Med. 2023;49(11):1305\u201316.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5817_CR14","doi-asserted-by":"publisher","first-page":"R72","DOI":"10.1186\/cc10061","volume":"15","author":"CJ Karvellas","year":"2011","unstructured":"Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15(1):R72.","journal-title":"Crit Care"},{"issue":"15","key":"5817_CR15","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","volume":"379","author":"SD Barbar","year":"2018","unstructured":"Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379(15):1431\u201342.","journal-title":"N Engl J Med"},{"key":"5817_CR16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603017","author":"S Gaudry","year":"2016","unstructured":"Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016. https:\/\/doi.org\/10.1056\/NEJMoa1603017.","journal-title":"N Engl J Med"},{"issue":"5","key":"5817_CR17","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1186\/cc13015","volume":"17","author":"LS Chawla","year":"2013","unstructured":"Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17(5):R207.","journal-title":"Crit Care"},{"issue":"1","key":"5817_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13054-020-02912-8","volume":"24","author":"JJ Chen","year":"2020","unstructured":"Chen JJ, Chang CH, Huang YT, Kuo G. Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis. Crit Care. 2020;24(1):202.","journal-title":"Crit Care"},{"issue":"4","key":"5817_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ki.2015.184","volume":"88","author":"R Wald","year":"2015","unstructured":"Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int. 2015;88(4):897\u2013904.","journal-title":"Kidney Int"},{"issue":"8","key":"5817_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/CCM.0000000000005849","volume":"51","author":"M Meersch","year":"2023","unstructured":"Meersch M, Weiss R, Gerss J, Albert F, Gruber J, Kellum JA, et al. Predicting the development of renal replacement therapy indications by combining the furosemide stress test and chemokine (C-C motif) ligand 14 in a cohort of postsurgical patients. Crit Care Med. 2023;51(8):1033\u201342.","journal-title":"Crit Care Med"},{"issue":"5","key":"5817_CR21","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/1744-9987.13787","volume":"26","author":"Q Xu","year":"2022","unstructured":"Xu Q, Jiang B, Li J, Lu W, Li J. Comparison of filter life span and solute removal during continuous renal replacement therapy: convection versus diffusion - a randomized controlled trial. Ther Apher Dial. 2022;26(5):1030\u20139.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"5817_CR22","doi-asserted-by":"publisher","first-page":"e0278550","DOI":"10.1371\/journal.pone.0278550","volume":"18","author":"L Mann","year":"2023","unstructured":"Mann L, Ten Eyck P, Wu C, Story M, Jenigiri S, Patel J, et al. Cvvhd results in longer filter life than pre-filter CVVH: results of a quasi-randomized clinical trial. PLoS One. 2023;18(1):e0278550.","journal-title":"PLoS One"},{"issue":"1","key":"5817_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000515641","volume":"51","author":"JM C\u00f4t\u00e9","year":"2022","unstructured":"C\u00f4t\u00e9 JM, Pinard L, Cailhier JF, L\u00e9vesque R, Murray PT, Beaubien-Souligny W. Intermittent convective therapies in patients with acute kidney injury: a systematic review with meta-analysis. Blood Purif. 2022;51(1):75\u201386.","journal-title":"Blood Purif"},{"issue":"16","key":"5817_CR24","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, Kullmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury a randomized clinical trial. JAMA. 2020;324(16):1629\u201339.","journal-title":"JAMA"},{"issue":"4","key":"5817_CR25","doi-asserted-by":"publisher","first-page":"c94","DOI":"10.1159\/000072492","volume":"94","author":"S Uchino","year":"2003","unstructured":"Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract. 2003;94(4):c94\u20138.","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"5817_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MAT.0b013e318201a599","volume":"57","author":"SA Nurmohamed","year":"2011","unstructured":"Nurmohamed SA, Jallah BP, Vervloet MG, Beishuizen A, Groeneveld AB. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin. ASAIO J. 2011;57(1):48\u201352.","journal-title":"ASAIO J"},{"issue":"4","key":"5817_CR27","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/cc11458","volume":"16","author":"JO Friedrich","year":"2012","unstructured":"Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16(4):R146.","journal-title":"Crit Care"},{"issue":"16","key":"5817_CR28","doi-asserted-by":"publisher","first-page":"e15257","DOI":"10.1097\/MD.0000000000015257","volume":"98","author":"J Zha","year":"2019","unstructured":"Zha J, Li C, Cheng G, Huang L, Bai Z, Fang C. The efficacy of renal replacement therapy strategies for septic-acute kidney injury: a PRISMA-compliant network meta-analysis. Medicine. 2019;98(16):e15257.","journal-title":"Medicine"},{"issue":"4\u20135","key":"5817_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1159\/000510982","volume":"50","author":"TAC Snow","year":"2021","unstructured":"Snow TAC, Littlewood S, Corredor C, Singer M, Arulkumaran N. Effect of extracorporeal blood purification on mortality in sepsis: a meta-analysis and trial sequential analysis. Blood Purif. 2021;50(4\u20135):462\u201372.","journal-title":"Blood Purif"},{"issue":"10","key":"5817_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1681\/ASN.20213210S1131a","volume":"32","author":"M Jang","year":"2021","unstructured":"Jang M. Survival comparison between continuous venovenous hemodiafiltration (CVVHDF) and continuous venovenous hemofiltration (CVVH) for septic AKI. J Am Soc Nephrol. 2021;32(10):131.","journal-title":"J Am Soc Nephrol"},{"key":"5817_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0509-8","author":"F D\u00e9pret","year":"2019","unstructured":"D\u00e9pret F, Peacock WF, Liu KD, Rafique Z, Rossignol P, Legrand M. Management of hyperkalemia in the acutely ill patient. Ann Intensive Care. 2019. https:\/\/doi.org\/10.1186\/s13613-019-0509-8.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"5817_CR32","volume":"2014","author":"X Zeng","year":"2014","unstructured":"Zeng X, Zhang L, Wu T, Fu P. Continuous renal replacement therapy (CRRT) for rhabdomyolysis. Cochrane Database Syst Rev. 2014;2014(6):CD008566.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"5817_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1399-6576.2007.01289.x","volume":"51","author":"S Peltonen","year":"2007","unstructured":"Peltonen S, Ahlstrom A, Kylavainio V, Honkanen E, Pettila V. The effect of combining intermittent hemodiafiltration with forced alkaline diuresis on plasma myoglobin in rhabdomyolysis. Acta Anaesthesiol Scand. 2007;51(5):553\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"5817_CR34","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s13054-020-03366-8","volume":"24","author":"L Weidhase","year":"2020","unstructured":"Weidhase L, de Fallois J, Haussig E, Kaiser T, Mende M, Petros S. Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial. Crit Care. 2020;24(1):644.","journal-title":"Crit Care"},{"key":"5817_CR35","volume":"3","author":"K Rabindranath","year":"2007","unstructured":"Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;3:CD003773.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"5817_CR36","volume":"3","author":"Z Ye","year":"2021","unstructured":"Ye Z, Wang Y, Ge L, Guyatt GH, Collister D, Alhazzani W, et al. Comparing renal replacement therapy modalities in critically ill patients with acute kidney injury: a systematic review and network meta-analysis. Crit Care Explor. 2021;3(5):e0399.","journal-title":"Crit Care Explor"},{"issue":"2","key":"5817_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/j.ajkd.2015.02.328","volume":"66","author":"L Zhang","year":"2015","unstructured":"Zhang L, Yang J, Eastwood GM, Zhu G, Tanaka A, Bellomo R. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis. 2015;66(2):322\u201330.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5817_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/nep.13009","volume":"22","author":"B Kovacs","year":"2017","unstructured":"Kovacs B, Sullivan KJ, Hiremath S, Patel RV. Effect of sustained low efficient dialysis versus continuous renal replacement therapy on renal recovery after acute kidney injury in the intensive care unit: a systematic review and meta-analysis. Nephrology. 2017;22(5):343\u201353.","journal-title":"Nephrology"},{"key":"5817_CR39","volume":"13","author":"T Schoenfelder","year":"2017","unstructured":"Schoenfelder T, Chen X, Bless HH. Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury. GMS Health Technol Assess. 2017;13:Doc01.","journal-title":"GMS Health Technol Assess"},{"issue":"1","key":"5817_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13054-022-04151-5","volume":"26","author":"T Naorungroj","year":"2022","unstructured":"Naorungroj T, Neto AS, Wang A, Gallagher M, Bellomo R. Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials. Crit Care. 2022;26(1):269.","journal-title":"Crit Care"},{"issue":"1","key":"5817_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13054-022-03936-y","volume":"26","author":"F Grolleau","year":"2022","unstructured":"Grolleau F, Porcher R, Barbar S, Hajage D, Bourredjem A, Quenot JP, et al. Personalization of renal replacement therapy initiation: a secondary analysis of the AKIKI and IDEAL-ICU trials. Crit Care. 2022;26(1):64.","journal-title":"Crit Care"},{"issue":"2","key":"5817_CR42","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/CCM.0000000000002796","volume":"46","author":"M Bonnassieux","year":"2018","unstructured":"Bonnassieux M, Duclos A, Schneider AG, Schmidt A, Benard S, Cancalon C, et al. Renal replacement therapy modality in the ICU and renal recovery at hospital discharge. Crit Care Med. 2018;46(2):e102\u201310.","journal-title":"Crit Care Med"},{"key":"5817_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4404-6","author":"AS Truche","year":"2016","unstructured":"Truche AS, Darmon M, Bailly S, Clec\u2019h C, Dupuis C, Misset B, et al. Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery. Intensive Care Med. 2016. https:\/\/doi.org\/10.1007\/s00134-016-4404-6.","journal-title":"Intensive Care Med"},{"key":"5817_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2024.154764","volume":"82","author":"JL Koyner","year":"2024","unstructured":"Koyner JL, Mackey RH, Echeverri J, Rosenthal NA, Carabuena LA, Bronson-Lowe D, et al. Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors. J Crit Care. 2024;82:154764.","journal-title":"J Crit Care"},{"issue":"1","key":"5817_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00885-7","volume":"11","author":"W Beaubien-Souligny","year":"2021","unstructured":"Beaubien-Souligny W, Yang Y, Burns KEA, Friedrich JO, Meraz-Munoz A, Clark EG, et al. Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy. Ann Intensive Care. 2021;11(1):96.","journal-title":"Ann Intensive Care"},{"issue":"5","key":"5817_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00063-021-00835-y","volume":"117","author":"C Willam","year":"2022","unstructured":"Willam C, Meersch M, Herbst L, Heering P, Schmitz M, Oppert M, et al. [Present practise patterns of renal replacement therapy in German intensive care medicine]. Med Klin Intensivmed Notfmed. 2022;117(5):367\u201373.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"5817_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.153998","volume":"69","author":"DS Russo","year":"2022","unstructured":"Russo DS, Eugenio CS, Balestrin IG, Rodrigues CG, Rosa RG, Teixeira C, et al. Comparison of hemodynamic instability among continuous, intermittent and hybrid renal replacement therapy in acute kidney injury: a systematic review of randomized clinical trials. J Crit Care. 2022;69:153998.","journal-title":"J Crit Care"},{"issue":"3","key":"5817_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000447543","volume":"133","author":"PK Guru","year":"2016","unstructured":"Guru PK, Singh TD, Akhoundi A, Kashani KB. Association of thrombocytopenia and mortality in critically ill patients on continuous renal replacement therapy. Nephron. 2016;133(3):175\u201382.","journal-title":"Nephron"},{"issue":"7","key":"5817_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000517232","volume":"51","author":"BR Griffin","year":"2022","unstructured":"Griffin BR, Ten Eyck P, Faubel S, Jalal D, Gallagher M, Bellomo R. Platelet decreases following continuous renal replacement therapy initiation as a novel risk factor for renal nonrecovery. Blood Purif. 2022;51(7):559\u201366.","journal-title":"Blood Purif"},{"issue":"6","key":"5817_CR50","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/0310057X1504300615","volume":"43","author":"R Pschowski","year":"2015","unstructured":"Pschowski R, Briegel S, Von Haehling S, Doehner W, Bender TO, Pape UF, et al. Effects of Dialysis modality on blood loss, bleeding complications and transfusion requirements in critically ill patients with Dialysis-dependent acute renal failure. Anaesth Intensive Care. 2015;43(6):764\u201370.","journal-title":"Anaesth Intensive Care"},{"issue":"9533","key":"5817_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(06)69111-3","volume":"368","author":"C Vinsonneau","year":"2006","unstructured":"Vinsonneau C, Camus C, Combes A, de Costa Beauregard MA, Klouche K, Boulain T, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368(9533):379\u201385.","journal-title":"Lancet"},{"issue":"4","key":"5817_CR52","doi-asserted-by":"publisher","first-page":"R140","DOI":"10.1186\/cc11445","volume":"16","author":"V Schwenger","year":"2012","unstructured":"Schwenger V, Weigand MA, Hoffmann O, Dikow R, Kihm LP, Seckinger J, et al. Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the renal replacement therapy study in intensive care unit patients. Crit Care. 2012;16(4):R140.","journal-title":"Crit Care"},{"issue":"11","key":"5817_CR53","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1161\/STROKEAHA.115.010985","volume":"46","author":"GN Nadkarni","year":"2015","unstructured":"Nadkarni GN, Patel AA, Konstantinidis I, Mahajan A, Agarwal SK, Kamat S, et al. Dialysis requiring acute kidney injury in acute cerebrovascular accident hospitalizations. Stroke. 2015;46(11):3226\u201331.","journal-title":"Stroke"},{"issue":"4","key":"5817_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/aas.13298","volume":"63","author":"A Lund","year":"2019","unstructured":"Lund A, Damholt MB, Wiis J, Kelsen J, Strange DG, Moller K. Intracranial pressure during hemodialysis in patients with acute brain injury. Acta Anaesthesiol Scand. 2019;63(4):493\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"key":"5817_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.wneu.2022.11.142","volume":"170","author":"AD Parsons","year":"2023","unstructured":"Parsons AD, Sanscrainte C, Leone A, Griepp DW, Rahme R. Dialysis disequilibrium syndrome and intracranial pressure fluctuations in neurosurgical patients undergoing renal replacement therapy: systematic review and pooled analysis. World Neurosurg. 2023;170:2\u20136.","journal-title":"World Neurosurg"},{"issue":"7","key":"5817_CR56","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/039139888901200706","volume":"12","author":"A Davenport","year":"1989","unstructured":"Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Miloszewski KJ, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs. 1989;12(7):439\u201344.","journal-title":"Int J Artif Organs"},{"issue":"5","key":"5817_CR57","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3171\/2013.4.JNS122102","volume":"119","author":"VC Wu","year":"2013","unstructured":"Wu VC, Huang TM, Shiao CC, Lai CF, Tsai PR, Wang WJ, et al. The hemodynamic effects during sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for uremic patients with brain hemorrhage: a crossover study. J Neurosurg. 2013;119(5):1288\u201395.","journal-title":"J Neurosurg"},{"key":"5817_CR58","doi-asserted-by":"crossref","unstructured":"Johansen N, Kjaergaard KD, Peters CD, Pedersen M, Jespersen B, Jensen JD. Brain swelling during dialysis: A randomized trial comparing low-flux hemodialysis with pre-dilution hemodiafiltration. Clinical nephrology. 2017;87 (2017)(5):221\u201330.","DOI":"10.5414\/CN108931"},{"issue":"12","key":"5817_CR59","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","volume":"48","author":"AS Messmer","year":"2020","unstructured":"Messmer AS, Zingg C, Muller M, Gerber JL, Schefold JC, Pfortmueller CA. Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies. Crit Care Med. 2020;48(12):1862\u201370.","journal-title":"Crit Care Med"},{"issue":"6","key":"5817_CR60","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1053\/j.ajkd.2004.08.022","volume":"44","author":"JJ Augustine","year":"2004","unstructured":"Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis. 2004;44(6):1000\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"5817_CR61","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ki.2009.159","volume":"76","author":"J Bouchard","year":"2009","unstructured":"Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422\u20137.","journal-title":"Kidney Int"},{"issue":"3","key":"5817_CR62","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1046\/j.1523-1755.2001.0600031154.x","volume":"60","author":"RL Mehta","year":"2001","unstructured":"Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int. 2001;60(3):1154\u201363.","journal-title":"Kidney Int"},{"issue":"5","key":"5817_CR63","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/aor.12408","volume":"39","author":"BB Albino","year":"2015","unstructured":"Albino BB, Balbi AL, Abrao JM, Ponce D. Dialysis complications in acute kidney injury patients treated with prolonged intermittent renal replacement therapy sessions lasting 10 versus 6 hours: results of a randomized clinical trial. Artif Organs. 2015;39(5):423\u201331.","journal-title":"Artif Organs"},{"key":"5817_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcrc.2021.03.011","volume":"64","author":"X Zhou","year":"2021","unstructured":"Zhou X, Dong P, Pan J, Wang H, Xu Z, Chen B. Renal replacement therapy modality in critically ill patients with acute kidney injury - a network meta-analysis of randomized controlled trials. J Crit Care. 2021;64:82\u201390.","journal-title":"J Crit Care"},{"issue":"51","key":"5817_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028118","volume":"100","author":"SA Dalbhi","year":"2021","unstructured":"Dalbhi SA, Alorf R, Alotaibi M, Altheaby A, Alghamdi Y, Ghazal H, et al. Sustained low efficiency dialysis is non-inferior to continuous renal replacement therapy in critically ill patients with acute kidney injury: a comparative meta-analysis. Medicine. 2021;100(51):e28118.","journal-title":"Medicine"},{"key":"5817_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccn.2023.103573","volume":"80","author":"N Daum","year":"2024","unstructured":"Daum N, Drewniok N, Bald A, Ulm B, Buyukli A, Grunow JJ, et al. Early mobilisation within 72 hours after admission of critically ill patients in the intensive care unit: a systematic review with network meta-analysis. Intensive Crit Care Nurs. 2024;80:103573.","journal-title":"Intensive Crit Care Nurs"},{"key":"5817_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1202754","volume":"10","author":"L Wang","year":"2023","unstructured":"Wang L, Hua Y, Wang L, Zou X, Zhang Y, Ou X. The effects of early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis. Front Med (Lausanne). 2023;10:1202754.","journal-title":"Front Med (Lausanne)"},{"key":"5817_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-024-01243-8","author":"L Zhou","year":"2025","unstructured":"Zhou L, Xie F, Zeng Y, Xia X, Wang R, Cai Y, et al. Preventive effects of early mobilisation on delirium incidence in critically ill patients: systematic review and meta-analysis. Med Klin Intensivmed Notfmed. 2025. https:\/\/doi.org\/10.1007\/s00063-024-01243-8.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"8","key":"5817_CR69","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00134-024-07532-2","volume":"50","author":"SJ Schaller","year":"2024","unstructured":"Schaller SJ, Scheffenbichler FT, Bein T, Blobner M, Grunow JJ, Hamsen U, et al. Guideline on positioning and early mobilisation in the critically ill by an expert panel. Intensive Care Med. 2024;50(8):1211\u201327.","journal-title":"Intensive Care Med"},{"issue":"2","key":"5817_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01823246-201324020-00003","volume":"24","author":"C Perme","year":"2013","unstructured":"Perme C, Nalty T, Winkelman C, Kenji Nawa R, Masud F. Safety and efficacy of mobility interventions in patients with femoral catheters in the ICU: a prospective observational study. Cardiopulm Phys Ther J. 2013;24(2):12\u20137.","journal-title":"Cardiopulm Phys Ther J"},{"issue":"5","key":"5817_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1513\/AnnalsATS.201506-359OC","volume":"13","author":"AL Toonstra","year":"2016","unstructured":"Toonstra AL, Zanni JM, Sperati CJ, Nelliot A, Mantheiy E, Skinner EH, et al. Feasibility and safety of physical therapy during continuous renal replacement therapy in the intensive care unit. Ann Am Thorac Soc. 2016;13(5):699\u2013704.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"5817_CR72","doi-asserted-by":"publisher","first-page":"e1112","DOI":"10.1097\/CCM.0000000000004526","volume":"48","author":"KP Mayer","year":"2020","unstructured":"Mayer KP, Joseph-Isang E, Robinson LE, Parry SM, Morris PE, Neyra JA. Safety and feasibility of physical rehabilitation and active mobilization in patients requiring continuous renal replacement therapy: a systematic review. Crit Care Med. 2020;48(11):e1112-20.","journal-title":"Crit Care Med"},{"issue":"6","key":"5817_CR73","volume":"2","author":"HA Bento","year":"2020","unstructured":"Bento HA, Dummer D, Lohse BD, Noren C, Tonna JE. Walking while dialyzing: a retrospective observation of early mobility and ambulation for patients on continuous renal replacement therapy. Crit Care Explor. 2020;2(6):e0131.","journal-title":"Crit Care Explor"},{"issue":"6","key":"5817_CR74","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00063-023-01035-6","volume":"118","author":"D Eggers","year":"2023","unstructured":"Eggers D, Hermes C, Esteve H, Nickoleit M, Filipovic S, Konig V, et al. [Interprofessional curriculum for early mobilization: developed by the nursing section of the DGIIN in close Cooperation with the German early mobilization network]. Med Klin Intensivmed Notfmed. 2023;118(6):487\u201391.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"2","key":"5817_CR75","first-page":"160","volume":"30","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xu S. Enhancing quality control in continuous renal replacement therapy through ICU specialist nursing care management program. Altern Ther Health Med. 2024;30(2):160\u20135.","journal-title":"Altern Ther Health Med"},{"issue":"5","key":"5817_CR76","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1513\/AnnalsATS.201509-586CME","volume":"13","author":"R Dubb","year":"2016","unstructured":"Dubb R, Nydahl P, Hermes C, Schwabbauer N, Toonstra A, Parker AM, et al. Barriers and strategies for early mobilization of patients in intensive care units. Ann Am Thorac Soc. 2016;13(5):724\u201330.","journal-title":"Ann Am Thorac Soc"},{"key":"5817_CR77","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.iccn.2018.12.005","volume":"52","author":"C Ragland","year":"2019","unstructured":"Ragland C, Ochoa L, Hartjes T. Early mobilisation in intensive care during renal replacement therapy: a quality improvement project. Intensive Crit Care Nurs. 2019;52:22\u20137.","journal-title":"Intensive Crit Care Nurs"},{"issue":"4","key":"5817_CR78","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/hdi.12433","volume":"20","author":"KC Leung","year":"2016","unstructured":"Leung KC, Tai DJ, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM. Citrate vs. acetate dialysate on intradialytic heparin dose: a double blind randomized crossover study. Hemodial Int Int Symp Home Hemodial. 2016;20(4):537\u201347.","journal-title":"Hemodial Int Int Symp Home Hemodial"},{"issue":"1","key":"5817_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/ijao.5000172","volume":"36","author":"BG Stegmayr","year":"2013","unstructured":"Stegmayr BG, Jonsson P, Mahmood D. A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation. Int J Artif Organs. 2013;36(1):1\u20136.","journal-title":"Int J Artif Organs"},{"issue":"2","key":"5817_CR80","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","volume":"37","author":"HM Oudemans-van Straaten","year":"2009","unstructured":"Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009;37(2):545\u201352.","journal-title":"Crit Care Med"},{"issue":"12","key":"5817_CR81","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","volume":"41","author":"M Bai","year":"2015","unstructured":"Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098\u2013110.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5817_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","volume":"20","author":"C Liu","year":"2016","unstructured":"Liu C, Mao Z, Kang H, Hu J, Zhou F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20(1):144.","journal-title":"Crit Care"},{"issue":"12","key":"5817_CR83","first-page":"CD012467","volume":"12","author":"H Tsujimoto","year":"2020","unstructured":"Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, et al. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev. 2020;12(12):CD012467.","journal-title":"Cochrane Database Syst Rev"},{"key":"5817_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/life13051198","author":"R Jacobs","year":"2023","unstructured":"Jacobs R, Verbrugghe W, Dams K, Roelant E, Couttenye MM, Devroey D, et al. Regional citrate anticoagulation in continuous renal replacement therapy: is metabolic fear the enemy of logic? A systematic review and meta-analysis of randomised controlled trials. Life. 2023. https:\/\/doi.org\/10.3390\/life13051198.","journal-title":"Life"},{"key":"5817_CR85","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231174001","volume":"29","author":"W Qi","year":"2023","unstructured":"Qi W, Liu J, Li A. Regional citrate anticoagulation or heparin anticoagulation for renal replacement therapy in patients with liver failure: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2023;29:10760296231174001.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"5817_CR86","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1164\/rccm.202201-0063LE","volume":"206","author":"J Gerss","year":"2022","unstructured":"Gerss J, Meersch M, Kindgen-Milles D, Brandenburger T, Willam C, Kellum JA, et al. The effect of filter lifespan during continuous renal replacement therapy in critically ill patients with acute kidney injury on the rate of new-onset infection: analysis from the RICH randomized controlled trial. Am J Respir Crit Care Med. 2022;206(4):511\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5817_CR87","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13054-023-04519-1","volume":"27","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):222.","journal-title":"Crit Care"},{"issue":"16","key":"5817_CR88","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, Kullmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324(16):1629\u201339.","journal-title":"JAMA"},{"key":"5817_CR89","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002501","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov D, Dahlinger A, Schelter C, Peters H, Kindgen-Milles D, Budde K, et al. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation. Crit Care Med. 2017. https:\/\/doi.org\/10.1097\/CCM.0000000000002501.","journal-title":"Crit Care Med"},{"issue":"4","key":"5817_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/cc11485","volume":"16","author":"C Schultheiss","year":"2012","unstructured":"Schultheiss C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care. 2012;16(4):R162.","journal-title":"Crit Care"},{"issue":"5","key":"5817_CR91","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0885066617701068","volume":"34","author":"JN Tan","year":"2019","unstructured":"Tan JN, Haroon SWP, Mukhopadhyay A, Lau T, Murali TM, Phua J, et al. Hyperlactatemia predicts citrate intolerance with regional citrate anticoagulation during continuous renal replacement therapy. J Intensive Care Med. 2019;34(5):418\u201325.","journal-title":"J Intensive Care Med"},{"key":"5817_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1031796","volume":"10","author":"B Peng","year":"2023","unstructured":"Peng B, Lu J, Guo H, Liu J, Li A. Regional citrate anticoagulation for replacement therapy in patients with liver failure: a systematic review and meta-analysis. Front Nutr. 2023;10:1031796.","journal-title":"Front Nutr"},{"issue":"1","key":"5817_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23(1):22.","journal-title":"Crit Care"},{"issue":"10","key":"5817_CR94","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1097\/00003246-199910000-00026","volume":"27","author":"JH Reeves","year":"1999","unstructured":"Reeves JH, Cumming AR, Gallagher L, O\u2019Brien JL, Santamaria JD. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med. 1999;27(10):2224\u20138.","journal-title":"Crit Care Med"},{"issue":"3","key":"5817_CR95","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3109\/08860221003606281","volume":"32","author":"EO Garces","year":"2010","unstructured":"Garces EO, Victorino JA, Thome FS, Rohsig LM, Dornelles E, Louzada M, et al. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial. Ren Fail. 2010;32(3):320\u20137.","journal-title":"Ren Fail"},{"issue":"9","key":"5817_CR96","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00134-007-0719-7","volume":"33","author":"M Joannidis","year":"2007","unstructured":"Joannidis M, Kountchev J, Rauchenzauner M, Schusterschitz N, Ulmer H, Mayr A, et al. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study. Intensive Care Med. 2007;33(9):1571\u20139.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5817_CR97","first-page":"CD011858","volume":"1","author":"P Natale","year":"2024","unstructured":"Natale P, Palmer SC, Ruospo M, Longmuir H, Dodds B, Prasad R, et al. Anticoagulation for people receiving long-term haemodialysis. Cochrane Database Syst Rev. 2024;1(1):CD011858.","journal-title":"Cochrane Database Syst Rev"},{"key":"5817_CR98","unstructured":"Shi M, Chen, H, Liu H, Qiu C, Jia R, Ding G. Anticoagulant elect of argatroban in ESRD patientsduring induction period of hemodialysis with central venous catheter access. J Ameerican Soc Nephrology. 2008;19."},{"issue":"9","key":"5817_CR99","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1093\/ndt\/gfq805","volume":"26","author":"X Sun","year":"2011","unstructured":"Sun X, Chen Y, Xiao Q, Wang Y, Zhou J, Ma Z, et al. Effects of Argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding. Nephrol Dial Transplant. 2011;26(9):2954\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"5817_CR100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/CCM.0b013e3181932394","volume":"37","author":"A Link","year":"2009","unstructured":"Link A, Girndt M, Selejan S, Mathes A, Bohm M, Rensing H. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med. 2009;37(1):105\u201310.","journal-title":"Crit Care Med"},{"issue":"10","key":"5817_CR101","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1345\/aph.1G033","volume":"39","author":"BV Reddy","year":"2005","unstructured":"Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PT. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy. Ann Pharmacother. 2005;39(10):1601\u20135.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"5817_CR102","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.jtcvs.2013.11.051","volume":"147","author":"M Klingele","year":"2014","unstructured":"Klingele M, Bomberg H, Lerner-Graber A, Fliser D, Poppleton A, Schafers HJ, et al. Use of argatroban: experiences in continuous renal replacement therapy in critically ill patients after cardiac surgery. J Thorac Cardiovasc Surg. 2014;147(6):1918\u201324.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"5817_CR103","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12882-020-02150-8","volume":"21","author":"F Arnold","year":"2020","unstructured":"Arnold F, Westermann L, Rieg S, Neumann-Haefelin E, Biever PM, Walz G, et al. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study. BMC Nephrol. 2020;21(1):486.","journal-title":"BMC Nephrol"},{"key":"5817_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0539-4","author":"H Yasuda","year":"2014","unstructured":"Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S, et al. The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care. 2014. https:\/\/doi.org\/10.1186\/s13054-014-0539-4.","journal-title":"Crit Care"},{"issue":"17","key":"5817_CR105","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"RRTS Investigators","year":"2009","unstructured":"Investigators RRTS, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627\u201338.","journal-title":"N Engl J Med"},{"issue":"7","key":"5817_CR106","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/ndt\/gfm938","volume":"23","author":"NS Kanagasundaram","year":"2008","unstructured":"Kanagasundaram NS, Greene T, Larive AB, Daugirdas JT, Depner TA, Paganini EP. Dosing intermittent haemodialysis in the intensive care unit patient with acute renal failure - estimation of urea removal and evidence for the regional blood flow model. Nephrol Dial Transplant. 2008;23(7):2286\u201398.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"5817_CR107","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/039139880703000309","volume":"30","author":"R Ratanarat","year":"2007","unstructured":"Ratanarat R, Permpikul C, Ronco C. Renal replacement therapy in acute renal failure: which index is best for dialysis dose quantification? Int J Artif Organs. 2007;30(3):235\u201343.","journal-title":"Int J Artif Organs"},{"issue":"3","key":"5817_CR108","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/01.CCM.0000054866.45509.D0","volume":"31","author":"M Brause","year":"2003","unstructured":"Brause M, Neumann A, Schumacher T, Grabensee B, Heering P. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units. Crit Care Med. 2003;31(3):841\u20136.","journal-title":"Crit Care Med"},{"issue":"5","key":"5817_CR109","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa010877","volume":"346","author":"H Schiffl","year":"2002","unstructured":"Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346(5):305\u201310.","journal-title":"N Engl J Med"},{"issue":"7","key":"5817_CR110","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/ndt\/gfp035","volume":"24","author":"R Faulhaber-Walter","year":"2009","unstructured":"Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H, et al. The Hannover dialysis outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant. 2009;24(7):2179\u201386.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"5817_CR111","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/CCM.0b013e3181d9d912","volume":"38","author":"R Van Wert","year":"2010","unstructured":"Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NK. High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med. 2010;38(5):1360\u20139.","journal-title":"Crit Care Med"},{"issue":"6","key":"5817_CR112","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/ndt\/gfx308","volume":"33","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, et al. Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis. Nephrol Dial Transplant. 2018;33(6):1017\u201324.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"5817_CR113","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","volume":"27","author":"C Ronco","year":"2003","unstructured":"Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27(9):792\u2013801.","journal-title":"Artif Organs"},{"issue":"3","key":"5817_CR114","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/01.CCM.0000115262.31804.46","volume":"32","author":"PM Honor\u00e9","year":"2004","unstructured":"Honor\u00e9 PM, Matson JR. Extracorporeal removal for sepsis:: acting at the tissue level -: the beginning of a new era for this treatment modality in septic shock. Crit Care Med. 2004;32(3):896\u20137.","journal-title":"Crit Care Med"},{"issue":"8","key":"5817_CR115","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/039139880502800803","volume":"28","author":"JV Di Carlo","year":"2005","unstructured":"Di Carlo JV, Alexander SR. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs. 2005;28(8):777\u201386.","journal-title":"Int J Artif Organs"},{"key":"5817_CR116","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000313773","volume-title":"Cardiorenal Syndromes in Critical Care","author":"ZY Peng","year":"2010","unstructured":"Peng ZY, Singbartl K, Simon P, Rimmel\u00e9 T, Bishop J, Clermont G, et al. Blood Purification in Sepsis: A New Paradigm. In: Cardiorenal Syndromes in Critical Care, vol. 165. 2010. p. 322\u20138."},{"key":"5817_CR117","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.12659\/MSM.916767","volume":"25","author":"Z Junhai","year":"2019","unstructured":"Junhai Z, Beibei C, Jing Y, Li L. Effect of high-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. Med Sci Monit. 2019;25:3964\u201375.","journal-title":"Med Sci Monit"},{"issue":"12","key":"5817_CR118","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/aor.14016","volume":"45","author":"H Huang","year":"2021","unstructured":"Huang H, Zhou Q, Chen M-H. High-volume hemofiltration reduces short-term mortality with no influence on the incidence of MODS, hospital stay, and hospitalization cost in patients with severe-acute pancreatitis: a meta-analysis. Artif Organs. 2021;45(12):1456\u201365.","journal-title":"Artif Organs"},{"issue":"22","key":"5817_CR119","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"S Finfer","year":"2004","unstructured":"Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247\u201356.","journal-title":"N Engl J Med"},{"key":"5817_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/cc10441","author":"J Gon\u00e7alves-Pereira","year":"2011","unstructured":"Gon\u00e7alves-Pereira J, P\u00f3voa P. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of \u03b2-lactams. Crit Care. 2011. https:\/\/doi.org\/10.1186\/cc10441.","journal-title":"Crit Care"},{"issue":"1","key":"5817_CR121","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10047-020-01214-8","volume":"24","author":"D Onichimowski","year":"2021","unstructured":"Onichimowski D, Nosek K, Ziolkowski H, Jaroszewski J, Pawlos A, Czuczwar M. Adsorption of vancomycin, gentamycin, Ciprofloxacin and Tygecycline on the filters in continuous renal replacement therapy circuits: in full blood in vitro study. J Artif Organs. 2021;24(1):65\u201373.","journal-title":"J Artif Organs"},{"issue":"3","key":"5817_CR122","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1186\/cc13886","volume":"18","author":"M Beumier","year":"2014","unstructured":"Beumier M, Casu GS, Hites M, Seyler L, Cotton F, Vincent JL, et al. beta-lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care. 2014;18(3):R105.","journal-title":"Crit Care"},{"issue":"3","key":"5817_CR123","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/cc10257","volume":"15","author":"L Seyler","year":"2011","unstructured":"Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, et al. Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care. 2011;15(3):R137.","journal-title":"Crit Care"},{"issue":"8","key":"5817_CR124","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, et al. Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis the BLING III randomized clinical trial. JAMA. 2024;332(8):629\u201337.","journal-title":"JAMA"},{"issue":"8","key":"5817_CR125","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"MH Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, et al. Prolonged vs intermittent infusions of \u03b2-lactam antibioticsin adults with sepsis or septic shock a systematic review and meta-analysis. JAMA. 2024;332(8):638\u201348.","journal-title":"JAMA"},{"issue":"8","key":"5817_CR126","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/phar.2842","volume":"43","author":"LT Hong","year":"2023","unstructured":"Hong LT, Downes KJ, FakhriRavari A, Abdul-Mutakabbir JC, Kuti JL, Jorgensen S, et al. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: endorsed by the American college of clinical Pharmacy, British society for antimicrobial Chemotherapy, cystic fibrosis Foundation, European society of clinical microbiology and infectious diseases, infectious diseases society of America, society of critical care Medicine, and society of infectious diseases pharmacists. Pharmacotherapy. 2023;43(8):740\u201377.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"5817_CR127","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper(). Intensive Care Med. 2020;46(6):1127\u201353.","journal-title":"Intensive Care Med"},{"key":"5817_CR128","volume":"8","author":"H Derendorf","year":"2020","unstructured":"Derendorf H, Heinrichs T, Reimers T, Lebert C, Brinkmann A. Calculated initial parenteral treatment of bacterial infections: pharmacokinetics and pharmacodynamics. GMS Infect Dis. 2020;8:Doc17.","journal-title":"GMS Infect Dis"},{"issue":"11","key":"5817_CR129","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"issue":"11","key":"5817_CR130","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1164\/rccm.201505-0857OC","volume":"192","author":"JM Dulhunty","year":"2015","unstructured":"Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, et al. A multicenter randomized trial of continuous versus intermittent beta-Lactam infusion in severe sepsis. Am J Respir Crit Care Med. 2015;192(11):1298\u2013305.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"5817_CR131","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","volume":"72","author":"JA Roberts","year":"2021","unstructured":"Roberts JA, Joynt GM, Lee A, Choi G, Bellomo R, Kanji S, et al. The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal replacement therapy study. Clin Infect Dis. 2021;72(8):1369\u201378.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5817_CR132","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijantimicag.2015.02.014","volume":"46","author":"JA Jamal","year":"2015","unstructured":"Jamal JA, Roberts DM, Udy AA, Mat-Nor MB, Mohamad-Nor FS, Wallis SC, et al. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;46(1):39\u201344.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5817_CR133","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijantimicag.2014.09.009","volume":"45","author":"JA Jamal","year":"2015","unstructured":"Jamal JA, Mat-Nor MB, Mohamad-Nor FS, Udy AA, Wallis SC, Lipman J, et al. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;45(1):41\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"5817_CR134","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00134-008-1034-7","volume":"34","author":"J Langgartner","year":"2008","unstructured":"Langgartner J, Vasold A, Gluck T, Reng M, Kees F. Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy. Intensive Care Med. 2008;34(6):1091\u20136.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5817_CR135","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/phar.2332","volume":"39","author":"CD Philpott","year":"2019","unstructured":"Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, et al. Pharmacokinetics and pharmacodynamics of extended-infusion cefepime in critically ill patients receiving continuous renal replacement therapy: a prospective, open-label study. Pharmacotherapy. 2019;39(11):1066\u201376.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"5817_CR136","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","volume":"47","author":"DC Richter","year":"2019","unstructured":"Richter DC, Frey O, Rohr A, Roberts JA, Koberer A, Fuchs T, et al. Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience. Infection. 2019;47(6):1001\u201311.","journal-title":"Infection"},{"issue":"9","key":"5817_CR137","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s00134-025-08067-w","volume":"51","author":"JA Roberts","year":"2025","unstructured":"Roberts JA, Ulldemolins M, Liu X, Baptista JP, Bilgrami I, Boidin C, et al. Meropenem and piperacillin\/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy. Intensive Care Med. 2025;51(9):1628\u201340.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5817_CR138","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"R Guilhaumou","year":"2019","unstructured":"Guilhaumou R, Benaboud S, Bennis Y, Dahyot-Fizelier C, Dailly E, Gandia P, et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French society of Pharmacology and therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French society of anaesthesia and intensive care medicine (Societe Francaise d\u2019anesthesie et Reanimation-SFAR). Crit Care. 2019;23(1):104.","journal-title":"Crit Care"},{"issue":"1","key":"5817_CR139","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/FTD.0000000000000941","volume":"44","author":"E Matusik","year":"2022","unstructured":"Matusik E, Boidin C, Friggeri A, Richard JC, Bitker L, Roberts JA, et al. Therapeutic drug monitoring of antibiotic drugs in patients receiving continuous renal replacement therapy or intermittent hemodialysis: a critical review. Ther Drug Monit. 2022;44(1):86\u2013102.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"5817_CR140","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","volume":"48","author":"S Hagel","year":"2022","unstructured":"Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, et al. Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med. 2022;48(3):311\u201321.","journal-title":"Intensive Care Med"},{"issue":"7","key":"5817_CR141","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cmi.2023.03.018","volume":"29","author":"M Sanz-Codina","year":"2023","unstructured":"Sanz-Codina M, Bozkir HO, Jorda A, Zeitlinger M. Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2023;29(7):845\u201357.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"issue":"3","key":"5817_CR142","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0272-6386(04)00810-8","volume":"44","author":"F Cantarovich","year":"2004","unstructured":"Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL, High-Dose Flurosemide in Acute Renal Failure Study G. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004;44(3):402\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5817_CR143","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/CCM.0b013e318195424d","volume":"37","author":"PH van der Voort","year":"2009","unstructured":"van der Voort PH, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med. 2009;37(2):533\u20138.","journal-title":"Crit Care Med"},{"issue":"1","key":"5817_CR144","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13054-020-2751-8","volume":"24","author":"RJ Katulka","year":"2020","unstructured":"Katulka RJ, Al Saadon A, Sebastianski M, Featherstone R, Vandermeer B, Silver SA, et al. Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT). Crit Care. 2020;24(1):50.","journal-title":"Crit Care"},{"issue":"3","key":"5817_CR145","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/cc13871","volume":"18","author":"PH van der Voort","year":"2014","unstructured":"van der Voort PH, Boerma EC, Pickkers P. The furosemide stress test to predict renal function after continuous renal replacement therapy. Crit Care. 2014;18(3):429.","journal-title":"Crit Care"},{"issue":"6","key":"5817_CR146","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1159\/000512350","volume":"50","author":"SI Baeg","year":"2021","unstructured":"Baeg SI, Jeon J, Yoo H, Na SJ, Kim K, Chung CR, et al. A scoring model with simple clinical parameters to predict successful discontinuation of continuous renal replacement therapy. Blood Purif. 2021;50(6):779\u201389.","journal-title":"Blood Purif"},{"issue":"1","key":"5817_CR147","first-page":"54","volume":"20","author":"TS Itenov","year":"2018","unstructured":"Itenov TS, Berthelsen RE, Jensen JU, Gerds TA, Pedersen LM, Strange D, et al. Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model. Crit Care Resusc. 2018;20(1):54\u201360.","journal-title":"Crit Care Resusc"},{"issue":"2","key":"5817_CR148","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/sdi.12936","volume":"34","author":"L Wang","year":"2021","unstructured":"Wang L, Li J, Sun S, Du H, Chen P, Xu Y, et al. Predictors of successful discontinuation from renal replacement therapy during AKI: a meta-analysis. Semin Dial. 2021;34(2):137\u201346.","journal-title":"Semin Dial"},{"key":"5817_CR149","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcrc.2020.07.012","volume":"60","author":"P Hansrivijit","year":"2020","unstructured":"Hansrivijit P, Yarlagadda K, Puthenpura MM, Ghahramani N, Thongprayoon C, Vaitla P, et al. A meta-analysis of clinical predictors for renal recovery and overall mortality in acute kidney injury requiring continuous renal replacement therapy. J Crit Care. 2020;60:13\u201322.","journal-title":"J Crit Care"},{"issue":"1","key":"5817_CR150","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13054-018-2192-9","volume":"22","author":"J Jeon","year":"2018","unstructured":"Jeon J, Kim DH, Baeg SI, Lee EJ, Chung CR, Jeon K, et al. Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Crit Care. 2018;22(1):255.","journal-title":"Crit Care"},{"issue":"3","key":"5817_CR151","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/nep.13396","volume":"24","author":"T Yoshida","year":"2019","unstructured":"Yoshida T, Matsuura R, Komaru Y, Miyamoto Y, Yoshimoto K, Hamasaki Y, et al. Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation. Nephrology. 2019;24(3):287\u201393.","journal-title":"Nephrology"},{"key":"5817_CR152","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcrc.2018.02.009","volume":"45","author":"JM Raurich","year":"2018","unstructured":"Raurich JM, Llompart-Pou JA, Novo MA, Talavera C, Ferreruela M, Ayestaran I. Successful weaning from continuous renal replacement therapy. Associated risk factors. J Crit Care. 2018;45:144\u20138.","journal-title":"J Crit Care"},{"issue":"1","key":"5817_CR153","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00134-007-0813-x","volume":"34","author":"VC Wu","year":"2008","unstructured":"Wu VC, Ko WJ, Chang HW, Chen YW, Lin YF, Shiao CC, et al. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med. 2008;34(1):101\u20138.","journal-title":"Intensive Care Med"},{"issue":"9","key":"5817_CR154","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1097\/CCM.0b013e3181a38241","volume":"37","author":"S Uchino","year":"2009","unstructured":"Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009;37(9):2576\u201382.","journal-title":"Crit Care Med"},{"issue":"3\u20134","key":"5817_CR155","first-page":"86","volume":"122","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Xu X, Ni H, Jin N. Serum cystatin C is associated with renal function recovery in critically ill patients undergoing continuous renal replacement therapy. Nephron Clin Pract. 2012;122(3\u20134):86\u201392.","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"5817_CR156","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/hdi.12532","volume":"22","author":"T Yang","year":"2018","unstructured":"Yang T, Sun S, Zhao Y, Liu Q, Han M, Lin L, et al. Biomarkers upon discontinuation of renal replacement therapy predict 60\u2010day survival and renal recovery in critically ill patients with acute kidney injury. Hemodial Int. 2018;22(1):56\u201365.","journal-title":"Hemodial Int"},{"issue":"3","key":"5817_CR157","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1159\/000490335","volume":"43","author":"CS Kim","year":"2018","unstructured":"Kim CS, Bae EH, Ma SK, Kim SW. A prospective observational study on the predictive value of serum cystatin C for successful weaning from continuous renal replacement therapy. Kidney Blood Press Res. 2018;43(3):872\u201381.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"5817_CR158","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000499026","volume":"48","author":"X Chen","year":"2019","unstructured":"Chen X, Chen Z, Wei T, Li P, Zhang L, Fu P. The effect of serum neutrophil gelatinase-associated lipocalin on the discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Blood Purif. 2019;48(1):10\u20137.","journal-title":"Blood Purif"},{"issue":"1","key":"5817_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02035-w","volume":"21","author":"J Thomsen","year":"2020","unstructured":"Thomsen J, Sprogoe U, Toft P. Urine neutrophil gelatinase-associated Lipocalin and urine output as predictors of the successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. BMC Nephrol. 2020;21(1):375.","journal-title":"BMC Nephrol"},{"issue":"3","key":"5817_CR160","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000501387","volume":"48","author":"S Stads","year":"2019","unstructured":"Stads S, Kant KM, de Jong MFC, de Ruijter W, Cobbaert CM, Betjes MGH, et al. Predictors of 90-day restart of renal replacement therapy after discontinuation of continuous renal replacement therapy, a prospective multicenter study. Blood Purif. 2019;48(3):243\u201352.","journal-title":"Blood Purif"},{"issue":"1","key":"5817_CR161","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/aor.14401","volume":"47","author":"CN Ohara","year":"2023","unstructured":"Ohara CN, Suarez MI, Kitawara KH, Zamoner W, Balbi AL, Ponce D. Factors predicting successful discontinuation of acute kidney replacement therapy: a retrospective cohort study. Artif Organs. 2023;47(1):187\u201397.","journal-title":"Artif Organs"},{"key":"5817_CR162","doi-asserted-by":"crossref","unstructured":"Volbeda M, Oord M, Koeze J et al. Criteria for Continuous Kidney Replacement Therapy Cessationin ICU Patients. Blood Purif. 2002;52(1):1-9","DOI":"10.1159\/000524180"},{"issue":"1","key":"5817_CR163","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000524180","volume":"52","author":"M Volbeda","year":"2023","unstructured":"Volbeda M, Oord M, Koeze J, Keus E, van der Horst ICC, Franssen CFM. Criteria for continuous kidney replacement therapy cessation in ICU patients. Blood Purif. 2023;52(1):32\u201340.","journal-title":"Blood Purif"},{"issue":"11","key":"5817_CR164","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.2215\/CJN.12651214","volume":"10","author":"A Dewitte","year":"2015","unstructured":"Dewitte A, Joannes-Boyau O, Sidobre C, Fleureau C, Bats ML, Derache P, et al. Kinetic eGFR and novel AKI biomarkers to predict renal recovery. Clin J Am Soc Nephrol. 2015;10(11):1900\u201310.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5817_CR165","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5935\/0103-507X.20160015","volume":"28","author":"SM Gaiao","year":"2016","unstructured":"Gaiao SM, Gomes AA, Paiva JA. Prognostics factors for mortality and renal recovery in critically ill patients with acute kidney injury and renal replacement therapy. Rev Bras Ter Intensiva. 2016;28(1):70\u20137.","journal-title":"Rev Bras Ter Intensiva"},{"issue":"2","key":"5817_CR166","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40620-021-01097-9","volume":"35","author":"K Shawwa","year":"2022","unstructured":"Shawwa K, Kompotiatis P, Sakhuja A, McCarthy P, Kashani KB. Prolonged exposure to continuous renal replacement therapy in patients with acute kidney injury. J Nephrol. 2022;35(2):585\u201395.","journal-title":"J Nephrol"},{"key":"5817_CR167","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-025-01293-6","author":"C Willam","year":"2025","unstructured":"Willam C, Abu-Tair M, Bayer M, Bellmann R, Brunkhorst F, Custodis F, et al. [S3 guideline on renal replacement therapy in intensive care medicine: Evidence-based implementation of renal replacement therapy in critically ill patients]. Med Klin Intensivmed Notfmed. 2025. https:\/\/doi.org\/10.1007\/s00063-025-01293-6.","journal-title":"Med Klin Intensivmed Notfmed"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05817-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:29:27Z","timestamp":1769527767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-025-05817-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5817"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05817-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is a consensus guideline article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All potential conflicts of interest were identified by the AWMF prior to the development of the guideline and are published under (https:\/\/register.awmf.org\/de\/leitlinien\/detail\/040-017).\u00a0Voting rights were defined in the event of a conflict of interest before the official consensus rounds took place.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}